Tianshui Zhongxing Bio-technology Co., Ltd. cancelled the acquisition of Hubei Gem Mushroom Garden Fungi Co., Ltd. from Zhang Xiaoping, Cao Yudi and Mianyang Garden Investment Group Co., Ltd
January 17, 2018
Share
Tianshui Zhongxing Bio-technology Co., Ltd. (SZSE:002772) signed a letter of intent to acquire Hubei Gem Mushroom Garden Fungi Co., Ltd. from Zhang Xiaoping, Cao Yudi and Mianyang Garden Investment Group Co., Ltd. for CNY 72 million on January 17, 2017. For the year ended December 31, 2016, Hubei Gem Mushroom Garden Fungi Co., Ltd. had total assets of CNY 110.66 million, net assets of CNY 52.82 million, revenue of CNY 2.71 million and net profit of CNY 1.1 million.
Tianshui Zhongxing Bio-technology Co., Ltd. (SZSE:002772) cancelled the acquisition of Hubei Gem Mushroom Garden Fungi Co., Ltd. from Zhang Xiaoping, Cao Yudi and Mianyang Garden Investment Group Co., Ltd on January 17, 2018.
Tianshui Zhongxing Bio-technology Co., Ltd. is principally engaged in the research and development, production and sale of edible mushroom. The Company's edible mushroom products include enoki mushroom, king oyster mushroom and beech mushroom. Through its subsidiaries, the Company also involves in the production and sale of edible mushroom, medicinal mushroom and auxiliary materials, research and development, application and promotion of microbial technology, biological engineering technology and new agricultural technologies, as well as the manufacture, process and distribution of agricultural by-products.
Tianshui Zhongxing Bio-technology Co., Ltd. cancelled the acquisition of Hubei Gem Mushroom Garden Fungi Co., Ltd. from Zhang Xiaoping, Cao Yudi and Mianyang Garden Investment Group Co., Ltd
TIANSHUI ZHONGXING BIO-TECHNOLOGY CO.,LTD. 
